Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 04, 2023

BUY
$131.14 - $157.47 $88,257 - $105,977
673 Added 4.45%
15,782 $0
Q3 2022

Oct 05, 2022

SELL
$148.29 - $182.55 $198,856 - $244,799
-1,341 Reduced 8.15%
15,109 $2.24 Million
Q2 2022

Jul 06, 2022

BUY
$155.97 - $200.09 $57,708 - $74,033
370 Added 2.3%
16,450 $2.83 Million
Q1 2022

Apr 05, 2022

BUY
$181.39 - $234.03 $49,882 - $64,358
275 Added 1.74%
16,080 $3.03 Million
Q4 2021

Jan 27, 2022

BUY
$193.69 - $247.03 $59,075 - $75,344
305 Added 1.97%
15,805 $3.86 Million
Q3 2021

Oct 06, 2021

BUY
$189.29 - $209.69 $10,221 - $11,323
54 Added 0.35%
15,500 $3.01 Million
Q2 2021

Jul 21, 2021

SELL
$155.9 - $187.99 $66,881 - $80,647
-429 Reduced 2.7%
15,446 $2.88 Million
Q1 2021

Apr 14, 2021

BUY
$144.0 - $169.39 $17,568 - $20,665
122 Added 0.77%
15,875 $2.5 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $660,636 - $733,316
4,206 Added 36.43%
15,753 $2.61 Million
Q3 2020

Oct 05, 2020

SELL
$137.1 - $165.37 $222,924 - $268,891
-1,626 Reduced 12.34%
11,547 $1.41 Million
Q2 2020

Jul 29, 2020

BUY
$111.92 - $142.53 $181,981 - $231,753
1,626 Added 14.08%
13,173 $1.81 Million
Q1 2020

Apr 08, 2020

BUY
$92.66 - $144.94 $1.07 Million - $1.67 Million
11,547 New
11,547 $1.41 Million
Q4 2019

Jan 06, 2020

SELL
$116.25 - $133.25 $1.34 Million - $1.54 Million
-11,547 Closed
0 $0
Q3 2019

Oct 03, 2019

BUY
$112.57 - $128.43 $16,660 - $19,007
148 Added 1.3%
11,547 $1.41 Million
Q2 2019

Jul 08, 2019

BUY
$97.98 - $114.28 $10,973 - $12,799
112 Added 0.99%
11,399 $1.29 Million
Q1 2019

Apr 09, 2019

SELL
$81.56 - $100.67 $69,733 - $86,072
-855 Reduced 7.04%
11,287 $1.14 Million
Q4 2018

Mar 19, 2019

BUY
$79.28 - $95.27 $962,617 - $1.16 Million
12,142 New
12,142 $1.04 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Centric Wealth Management Portfolio

Follow Centric Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.